Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.

Background: Neutropenia is a major adverse event often associated with chemotherapy administration. Neutropenia-related complications often lead to increased use of costly health care including inpatient and outpatient services. Monitoring and treatment of neutropenia thus place an economic burden on the health care system.